Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Heering

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Sciences|October 29, 2020
Chemical Starting Matter for HNF4α Ligand Discovery and ChemogenomicsIsabelle Meijer, Sabine Willems, Xiaomin Ni, et al.
Iscience|December 22, 2021
Closantel is an allosteric inhibitor of human Taspase1Vanessa Luciano, Ewgenij Proschak, Julian D Langer, et al.
Journal of Bacteriology|July 1, 2015
Cyclic Di-GMP Regulates Type IV Pilus-Dependent Motility in Myxococcus xanthusDorota Skotnicka, Tobias Petters, Jan Heering, et al.
American Journal of Medical Genetics. Part A|January 5, 2011
Phenotypic analysis of Arg227 mutations of TP63 with emphasis on dental phenotype and micturition difficulties in EEC syndromeWarissara Sripathomsawat, Pranoot Tanpaiboon, Jan Heering, et al.
Communications Chemistry|January 27, 2023
The orphan nuclear receptor Nurr1 is responsive to non-steroidal anti-inflammatory drugsSabine Willems, Whitney Kilu, Xiaomin Ni, et al.
International Journal of Molecular Sciences|November 14, 2020
Comprehensive Set of Tertiary Complex Structures and Palmitic Acid Binding Provide Molecular Insights into Ligand Design for RXR IsoformsApirat Chaikuad, Julius Pollinger, Michael Rühl, et al.
Journal of Medicinal Chemistry|January 6, 2022
Design of a Potent TLX Agonist by Rational Fragment FusionGiuseppe Faudone, Rezart Zhubi, Fatih Celik, et al.
ACS Medicinal Chemistry Letters|February 21, 2019
Computer-Assisted Discovery and Structural Optimization of a Novel Retinoid X Receptor Agonist ChemotypePascal Heitel, Leonie Gellrich, Lena Kalinowsky, et al.
American Journal of Medical Genetics. Part A|May 14, 2011
Mutation in SAM domain of TP63 is associated with nonsyndromic cleft lip and palate and cleft palatePiranit N Kantaputra, Sutti Malaivijitnond, Alexandre R Vieira, et al.
Communications Chemistry|May 21, 2025
Structural and mechanistic profiling of Nurr1 modulation by vidofludimus enables structure-guided ligand designÚrsula López-García, Jan Vietor, Julian A Marschner, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|October 29, 2020
Chemical Starting Matter for HNF4α Ligand Discovery and ChemogenomicsIsabelle Meijer, Sabine Willems, Xiaomin Ni, et al.
Iscience|December 22, 2021
Closantel is an allosteric inhibitor of human Taspase1Vanessa Luciano, Ewgenij Proschak, Julian D Langer, et al.
Journal of Bacteriology|July 1, 2015
Cyclic Di-GMP Regulates Type IV Pilus-Dependent Motility in Myxococcus xanthusDorota Skotnicka, Tobias Petters, Jan Heering, et al.
American Journal of Medical Genetics. Part A|January 5, 2011
Phenotypic analysis of Arg227 mutations of TP63 with emphasis on dental phenotype and micturition difficulties in EEC syndromeWarissara Sripathomsawat, Pranoot Tanpaiboon, Jan Heering, et al.
Communications Chemistry|January 27, 2023
The orphan nuclear receptor Nurr1 is responsive to non-steroidal anti-inflammatory drugsSabine Willems, Whitney Kilu, Xiaomin Ni, et al.
International Journal of Molecular Sciences|November 14, 2020
Comprehensive Set of Tertiary Complex Structures and Palmitic Acid Binding Provide Molecular Insights into Ligand Design for RXR IsoformsApirat Chaikuad, Julius Pollinger, Michael Rühl, et al.
Journal of Medicinal Chemistry|January 6, 2022
Design of a Potent TLX Agonist by Rational Fragment FusionGiuseppe Faudone, Rezart Zhubi, Fatih Celik, et al.
ACS Medicinal Chemistry Letters|February 21, 2019
Computer-Assisted Discovery and Structural Optimization of a Novel Retinoid X Receptor Agonist ChemotypePascal Heitel, Leonie Gellrich, Lena Kalinowsky, et al.
American Journal of Medical Genetics. Part A|May 14, 2011
Mutation in SAM domain of TP63 is associated with nonsyndromic cleft lip and palate and cleft palatePiranit N Kantaputra, Sutti Malaivijitnond, Alexandre R Vieira, et al.
Communications Chemistry|May 21, 2025
Structural and mechanistic profiling of Nurr1 modulation by vidofludimus enables structure-guided ligand designÚrsula López-García, Jan Vietor, Julian A Marschner, et al.
Pageof 8